By Ms Katrina Blazek

Journal articles

Hilton HN; Kalyuga M; Cowley MJ; Alles MC; Lee HJ; Caldon CE; Blazek K; Kaplan W; Musgrove EA; Daly RJ; Naylor MJ; Graham J; Clarke C; Ormandy CJ, 2010, 'The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5', Molecular Endocrinology, 24, pp. 1380 - 1392, http://dx.doi.org/10.1210/me.2009-0516

Oakes SR; Naylor MJ; Asselin-Labat M; Blazek K; Gardiner-Garden M; Hilton HN; Kazlauskas M; Pritchard M; Chodosh L; Pfeffer P; Lindeman GJ; Visvader J; Ormandy CJ, 2008, 'The Ets transcription factor Elf5 specifies mammary alveolar cell fate', Genes and Development, 22, pp. 581 - 586, http://dx.doi.org/10.1101/gad.1614608

Craven AJ; Nixon AJ; Ashby MG; Ormandy CJ; Blazek K; Wilkins RJ; Pearson AJ, 2006, 'Prolactin delays hair regrowth in mice', Journal of Endocrinology, 191, pp. 415 - 425

Harris J; Stanford PM; Sutherland K; Oakes SR; Naylor MJ; Robertson F; Blazek K; Kazlauskas M; Hilton HN; Wittlin S; Alexander WS; Lindeman GJ; Visvader J; Ormandy CJ, 2006, 'Socs2 and Elf5 mediate prolactin-induced mammary gland development', Molecular Endocrinology, 20, pp. 1177 - 1187

Naylor MJ; Oakes SR; Gardiner-Garden M; Harris J; Blazek K; Ho TW; Li F; Wynick D; Walker AM; Ormandy CJ, 2005, 'Transcriptional changes underlying the secretory activation phase of mammary gland development', Molecular Endocrinology, 19, pp. 1868 - 1883

Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD, 2004, 'Mouse mammary tumor like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer', Clinical Cancer Research, 10, pp. 4417 - 4419

Back to profile page